Biliary Tract Cancer: From Molecular Mechanism to Therapeutic Perspectives
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: closed (30 June 2025) | Viewed by 865
Special Issue Editor
Special Issue Information
Dear Colleagues,
The incidence of biliary tract cancers has been rapidly increasing in recent years. Despite the emergence of FDA-approved drugs for these cancers, mortality rates remain high, and challenges with drug inefficacy and resistance persist. Biliary tract cancers are heterogeneous in nature, with diverse etiologies compounding the challenge of developing effective drug therapies. Elucidating the molecular mechanisms underlying the progression and development of biliary tract cancers is crucial for identifying new targetable vulnerabilities. This research promises to accelerate the drug discovery process for novel therapeutic strategies, though much work remains to be conducted. This Special Issue invites original basic science and translational work in the field to highlight recent scientific findings that could potentially impact patient care.
Dr. Jing Han Hong
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biliary tract cancers
- molecular mechanisms
- drug discovery
- therapeutic vulnerabilities
- translational science
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
